Cellebrite DI Ltd. Form 6-K Summary
Business Context and Reporting Period
This Form 6-K, filed on September 18, 2024, reports on the completion of the redemption of all outstanding public and private placement warrants for Cellebrite DI Ltd. The filing details the execution of a previously announced redemption at a price of $0.10 per warrant.
Key Financial Metrics and Capital Structure Changes
The filing focuses on capital structure adjustments rather than operational financial performance. Key metrics include:
- Redemption Price: $0.10 per warrant.
- Public Warrants Exercised: 19,883,225 of 19,999,449 outstanding (99.4%).
- Shares Issued from Public Warrants: 6,803,085 Ordinary Shares (4,645 via cash exercise at $11.50/share; 6,798,440 via cashless exercise).
- Public Warrants Redeemed: 116,224 unexercised warrants redeemed for an aggregate of $11,622.40.
- Private Placement Warrants: All 9,666,667 warrants exercised on a cashless basis, resulting in 3,306,000 Ordinary Shares.
- Outstanding Warrants: Zero Public Warrants remain outstanding following the redemption.
Material Changes Versus Prior Period
The primary material change is the complete elimination of the Company's public warrant liability. Public warrants have been delisted from the Nasdaq Global Select Market. The Company's Ordinary Shares (ticker: CLBT) continue to trade unaffected.
Outlook, Risks, and Contingencies
Contingency on Private Placement Shares: The issuance of the 3,306,000 Ordinary Shares from the Private Placement Warrants is contingent upon the holder obtaining an exemption from withholding tax from the Israeli Tax Authority (ITA). The holder has been granted an extension until February 25, 2025, to secure this exemption. Shares will not be issued until the exemption is obtained or the outside date is reached, whichever is earlier.
Legal Disclaimer: The filing and attached press release do not constitute an offer to sell or a solicitation of an offer to buy securities.
Investor Verification Checklist
- Verify the final count of Ordinary Shares issued upon the resolution of the Private Placement Warrant tax exemption.
- Confirm the delisting status of Public Warrants on Nasdaq.
- Review the impact of the 6,803,085 new shares from Public Warrants on existing shareholder dilution.
- Note that the filing does not provide updated revenue, profit, or cash flow data for the period.